Dr. Reddy’s Aurigene Unit Opens New Indian Biologics Facility

Announcement Follows Deals Made By Aurigene And Dr. Reddy

The Dr. Reddy subsidiary CRDMO Aurigene has opened a new biologics facility in India, with plans to finish the plant’s manufacturing capabilities later this year.

Illustration of Hyderabad
• Source: Shutterstock

More from Biosimilars

More from Products